These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 5312936)

  • 1. Species difference in drug metabolism by liver microsomes in alloxan diabetic or fasted animals. I. The activity of drug-metabolizing enzymes and electron transport system.
    Kato R; Onoda K; Takanaka A
    Jpn J Pharmacol; 1970 Dec; 20(4):546-53. PubMed ID: 5312936
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on age difference in mice for the activity of drug-metabolizing enzymes of liver microsomes.
    Kato R; Takanaka A; Onoda K
    Jpn J Pharmacol; 1970 Dec; 20(4):572-6. PubMed ID: 5312939
    [No Abstract]   [Full Text] [Related]  

  • 3. Species difference in drug metabolism by liver microsomes in alloxan diabetic or fasted animals. II. The substrate interaction with cytochrome P-450 in drug oxidation.
    Kato R; Onoda K; Takanaka A
    Jpn J Pharmacol; 1970 Dec; 20(4):554-61. PubMed ID: 5312937
    [No Abstract]   [Full Text] [Related]  

  • 4. Some observations on the microsomal electron transport system and activities of drug oxidizing enzymes in human liver.
    Kamataki T; Kitada M; Kitagawa H
    Chem Pharm Bull (Tokyo); 1973 Jan; 21(1):8-11. PubMed ID: 4711517
    [No Abstract]   [Full Text] [Related]  

  • 5. Species differences in the alteration of drug-metabolizing activities of liver microsomes by thyroxine treatment.
    Kato R; Takanaka A; Takahashi A; Onoda K
    Jpn J Pharmacol; 1969 Mar; 19(1):5-18. PubMed ID: 4389560
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of adrenalectomy or alloxan diabetes on the substrate interaction with cytochrome P-450 in the oxidation of drugs by liver microsomes.
    Kato R; Takanaka A; Onoda K
    Biochem Pharmacol; 1971 Feb; 20(2):447-58. PubMed ID: 5150143
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the mechanism of sex difference in drug-oxidizing activity of liver microsomes.
    Kato R; Takanaka A; Takayanagi M
    Jpn J Pharmacol; 1968 Dec; 18(4):482-9. PubMed ID: 4388258
    [No Abstract]   [Full Text] [Related]  

  • 8. Kinetic parameters of drug-metabolizing enzymes in Ca 2+ -sedimented microsomes from rat liver.
    Cinti DL; Moldeus P; Schenkman JB
    Biochem Pharmacol; 1972 Dec; 21(24):3249-56. PubMed ID: 4405367
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of starvation on the kinetics of drug oxidation by hepatic microsomal enzymes from male and female rats.
    Gram TE; Guarino AM; Schroeder DH; Davis DC; Reagan RL; Gillette JR
    J Pharmacol Exp Ther; 1970 Oct; 175(1):12-21. PubMed ID: 5471443
    [No Abstract]   [Full Text] [Related]  

  • 10. Thyroid hormone and activities of drug-metabolizing enzymes and electron transport systems of rat liver microsomes.
    Kato R; Takahashi A
    Mol Pharmacol; 1968 Mar; 4(2):109-20. PubMed ID: 5645609
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of drugs in old rats. I. Activities of NADPH-linked electron transport and drug-metabolizing enzyme systems in liver microsomes of old rats.
    Kato R; Takanaka A
    Jpn J Pharmacol; 1968 Dec; 18(4):381-8. PubMed ID: 4388257
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of carbon tetrachloride on endoplasmic enzymes in rat liver].
    Heni N; Remmer H
    Arch Toxikol; 1971; 28(1):1-11. PubMed ID: 4328041
    [No Abstract]   [Full Text] [Related]  

  • 13. Possible role of P-450 in the oxidation of drugs in liver microsomes.
    Kato R
    J Biochem; 1966 Jun; 59(6):574-83. PubMed ID: 4381416
    [No Abstract]   [Full Text] [Related]  

  • 14. Strain differences in the metabolism and action of drugs in mice and rats.
    Kato R; Onoda K; Takanaka A
    Jpn J Pharmacol; 1970 Dec; 20(4):562-71. PubMed ID: 5312938
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of morphine treatment and starvation on the substrate interaction with P-450 in the oxidation of drugs by liver microsomes.
    Kato R; Onoda K; Sasajima M
    Jpn J Pharmacol; 1970 Jun; 20(2):194-209. PubMed ID: 4393947
    [No Abstract]   [Full Text] [Related]  

  • 16. The presence of a monooxygenase system in human fetal liver microsomes.
    Yaffe SJ; Rane A; Sjöqvist F; Boréus LO; Orrenius S
    Life Sci II; 1970 Oct; 9(20):1189-200. PubMed ID: 4394558
    [No Abstract]   [Full Text] [Related]  

  • 17. The diphasic action of halothane on the oxidative metabolism of drugs by the liver. An in-vitro study in the rat.
    Brown BR
    Anesthesiology; 1971 Sep; 35(3):241-6. PubMed ID: 5095536
    [No Abstract]   [Full Text] [Related]  

  • 18. Species differences in the effect of morphine administration or adrenalectomy on the substrate interactions with cytochrome P-450 and drug oxidations by liver microsomes.
    Kato R; Onoda KI; Takanaka A
    Biochem Pharmacol; 1971 Jun; 20(6):1093-9. PubMed ID: 5118111
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of thiamine consumption on liver microsomal drug-metabolizing pathways.
    Grosse W; Wade AE
    J Pharmacol Exp Ther; 1971 Mar; 176(3):758-65. PubMed ID: 4398746
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of thyroid hormone on the substrate interaction with P-450 in the oxidation of drugs by liver microsomes.
    Kato R; Takanaka A; Takahashi A
    J Biochem; 1970 Nov; 68(5):613-23. PubMed ID: 5484443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.